Acupuncture at Huatuo Jiaji Points for Yang Qi Stagnation-Related Adolescent Depression: A Clinical Trial and Protocol Development

注册号:

Registration number:

ITMCTR2025001452

最近更新日期:

Date of Last Refreshed on:

2025-07-21

注册时间:

Date of Registration:

2025-07-21

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

针刺华佗夹脊穴为主治疗阳气郁滞型青少年抑郁症的临床研究与诊疗方案转化

Public title:

Acupuncture at Huatuo Jiaji Points for Yang Qi Stagnation-Related Adolescent Depression: A Clinical Trial and Protocol Development

注册题目简写:

English Acronym:

研究课题的正式科学名称:

针刺华佗夹脊穴为主治疗阳气郁滞型青少年抑郁症的临床研究与诊疗方案转化

Scientific title:

Acupuncture at Huatuo Jiaji Points for Yang Qi Stagnation-Related Adolescent Depression: A Clinical Trial and Protocol Development

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

汪俊丽

研究负责人:

王颖

Applicant:

Wang Jun-li

Study leader:

Wang Ying

申请注册联系人电话:

Applicant telephone:

19966463846

研究负责人电话:

Study leader's telephone:

13955199550

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

2985463626@qq.com

研究负责人电子邮件:

Study leader's E-mail:

zhenjiu205@126.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

安徽省合肥市庐阳区寿春路300号

研究负责人通讯地址:

安徽省合肥市庐阳区寿春路300号

Applicant address:

No. 300 Shouchun Road Luyang District Hefei City Anhui Province

Study leader's address:

No. 300 Shouchun Road Luyang District Hefei City Anhui Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

安徽中医药大学第二附属医院

Applicant's institution:

The Second Affiliated Hospital of Anhui University of Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2024-zjpj-27

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

安徽中医药大学第二附属医院伦理委员会

Name of the ethic committee:

Ethics Committee of the Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2024/12/31 0:00:00

伦理委员会联系人:

束樱子

Contact Name of the ethic committee:

Shu Yingzi

伦理委员会联系地址:

安徽省合肥市庐阳区寿春路300号安徽中医药大学第二附属医院

Contact Address of the ethic committee:

300 Shouchun Road Luyang District Hefei Anhui

伦理委员会联系人电话:

Contact phone of the ethic committee:

0551-62668814

伦理委员会联系人邮箱:

Contact email of the ethic committee:

ahzjyykjk@163.com

研究实施负责(组长)单位:

安徽中医药大学第二附属医院

Primary sponsor:

The Second Affiliated Hospital of Anhui University of Chinese Medicine

研究实施负责(组长)单位地址:

安徽省合肥市庐阳区寿春路300号

Primary sponsor's address:

No. 300 Shouchun Road Luyang District Hefei City Anhui Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

安徽

市(区县):

合肥

Country:

China

Province:

Anhui

City:

Hefei

单位(医院):

安徽中医药大学第二附属医院

具体地址:

安徽省合肥市庐阳区寿春路300号

Institution
hospital:

The Second Affiliated Hospital of Anhui University of Chinese Medicine

Address:

No.300 Shouchun Road Luyang District

经费或物资来源:

安徽省华佗中医药研究院科技重大专项(BZKZ2405)

Source(s) of funding:

Major research project supported by Anhui Huatuo Academy of Traditional Chinese Medicine(BZKZ2405)

研究疾病:

青少年抑郁症

研究疾病代码:

Target disease:

Adolescent depression

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

分析针刺华佗夹脊穴为主治疗阳气郁滞型青少年抑郁症的临床疗效与安全性,促进制定具具有华佗医学特色的青少年抑郁症中西医结合诊疗方案。

Objectives of Study:

To analyze the clinical efficacy and safety of acupuncture Huatuo chiropractic acupoint in the treatment of adolescent depression with yang qi stagnation and to promote the formulation of a diagnosis and treatment plan of integrated traditional Chinese and Western medicine for adolescent depression with Huatuo medical characteristics.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

①符合 ICD-10 中抑郁障碍及阳气郁滞型郁病的诊断标准;②年龄 13~18 岁,意识清醒,无失语、智能障碍,文化程度初中(含)以上,能理解量表内容并配合治疗;③7 分<HAMD-17 评分<24 分;④临床查体及实验室检查无明显异常;⑤签署知情同意书者。

Inclusion criteria

(1) Meet the diagnostic criteria for depressive disorder and yang qi stagnation depression in ICD-10; (2) Age 13~18 years old conscious no aphasia intellectual disability education level junior high school (inclusive) or above able to understand the content of the scale and cooperate with treatment; (3) 7 points< HAMD-17 score<24 points; (4) There is no obvious abnormality in clinical examination and laboratory examination; (5) Those who have signed the informed consent form.

排除标准:

①不能配合针灸治疗;②癫痫发作史或强阳性癫痫家族史、脑器质性疾病及严重躯体疾病史者;③患有严重神经系统疾病及心、脑、肾等躯体疾病者;④有药物毒品或乙醇等滥用史者;⑤合并有皮损或皮肤病、严重糖尿病、肿瘤及重要脏器功能不全或严重肝、肾、心血管、内分泌、呼吸系统和造血系统等内科疾病者;⑥妊娠、备孕或哺乳期。

Exclusion criteria:

(1) Unable to cooperate with acupuncture treatment; (2) History of seizures or strong positive family history of epilepsy, history of cerebral organic diseases and serious physical diseases; (3) Those who suffer from severe neurological diseases and physical diseases such as heart, brain, and kidney; (4) Those who have a history of abuse of drugs, drugs or ethanol; (5) Patients with skin lesions or skin diseases, severe diabetes, tumors and insufficiency of important organs, or serious internal diseases such as liver, kidney, cardiovascular, endocrine, respiratory and hematopoietic systems; (6) Pregnancy, trying to conceive or lactation.

研究实施时间:

Study execute time:

From 2024-10-01

To      2026-12-31

征募观察对象时间:

Recruiting time:

From 2025-09-01

To      2026-12-31

干预措施:

Interventions:

组别:

假针刺组

样本量:

37

Group:

Sham acupuncture group

Sample size:

干预措施:

在对照组治疗基础上,予以假针刺治疗

干预措施代码:

Intervention:

On the basis of the treatment in the control group sham acupuncture treatment was given

Intervention code:

组别:

针刺组

样本量:

37

Group:

Acupuncture group

Sample size:

干预措施:

在对照组治疗基础上,予以针刺华佗夹脊穴为主治疗

干预措施代码:

Intervention:

On the basis of the treatment of the control group acupuncture Huatuo chiropractic point was the main treatment

Intervention code:

组别:

对照组

样本量:

37

Group:

Control group

Sample size:

干预措施:

采用单纯抗抑郁西药治疗

干预措施代码:

Intervention:

Treatment with antidepressant drugs alone

Intervention code:

样本总量 Total sample size : 111

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

安徽

市(区县):

合肥

Country:

China

Province:

Anhui

City:

Hefei

单位(医院):

安徽中医药大学第二附属医院

单位级别:

三级甲等医院

Institution/hospital:

The Second Affiliated Hospital of Anhui University of Chinese Medicine

Level of the institution:

tertiary hospital

国家:

中国

省(直辖市):

安徽

市(区县):

合肥市

Country:

China

Province:

Anhui

City:

Hefei

单位(医院):

合肥市第四人民医院

单位级别:

三级甲等精神专科医院

Institution/hospital:

Hefei Fourth People's Hospital

Level of the institution:

A tertiary psychiatric hospital

国家:

中国

省(直辖市):

广东

市(区县):

广州市

Country:

China

Province:

Anhui

City:

Hefei

单位(医院):

广州医科大学附属脑科医院

单位级别:

三级甲等精神专科医院

Institution/hospital:

The Affiliated Brain Hospital of Guangzhou Medical University

Level of the institution:

A tertiary psychiatric hospital

测量指标:

Outcomes:

指标中文名:

健康状况调查简表

指标类型:

次要指标

Outcome:

36-item short form health survey

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

汉密尔顿焦虑量表

指标类型:

次要指标

Outcome:

Hamilton anxiety scale

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

精神分裂症认知功能成套测验

指标类型:

次要指标

Outcome:

MATRICS Consensus Cognitive Battery

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

汉密尔顿抑郁量表-17

指标类型:

主要指标

Outcome:

Hamilton Depression Scale-17

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

匹兹堡睡眠质量指数

指标类型:

次要指标

Outcome:

Pittsburgh sleep quality index

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

身高、体重、腰围、BMI 等基本信息及血糖、血脂等常规指标

指标类型:

次要指标

Outcome:

Basic information such as height, weight, waist circumference, BMI, and regular fingers such as blood sugar and blood lipids

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它

说明

Fate of sample 

Others

Note:

征募研究对象情况:

尚未开始

Not yet recruiting

年龄范围:

最小 13
Min age years
最大 18
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

按患者纳入顺序取编号1-111,应用SPSS25.0软件生成与1-111相对应的随机数字,将随机数字分别对应1、2、3,其中1为对照组,2为假针刺组,3为针刺组,患者按照入组顺序分配随机数字编号,并对应产生分组,每组37例。

Randomization Procedure (please state who generates the random number sequence and by what method):

The numbers 1-111 were taken according to the order of patient inclusion, and the random numbers corresponding to 1-111 were generated by SPSS25.0 software, and the random numbers corresponded to 1, 2 and 3 respectively, of which 1 was the control group, 2 was the sham acupuncture group, and 3 was the acupuncture group, and the random number numbers were assigned to the patients according to the enrollment order, and the corresponding groups were generated, with 37 cases in each group.

盲法:

Blinding:

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

ResMan临床试验公共管理平台

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

ResMan Clinical Trial Management Public Platform http://www.medresman.org.cn/uc/index.aspx

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

本临床试验采用电子数据采集系统(EDC)收集病例报告表数据。临床数据管理员根据临床试验方案设计病例报告表(CRF),包括研究流程、数据表单名称及其收集的数据项;由数据库程序员根据 CRF 来构建电子病例报告表(eCRF),搭建 EDC 数据库。由临床数据管理员撰写 eCRF 填写指南。临床数据管理员(CDM)根据临床试验方案制定数据管理计划(DMP)。数据管理计划作为整个数据管理过程的指导性文件,数据管理所有过程均应按照其中定义的时间、内容及方法进行操作。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

In this clinical trial, an electronic data collection system (EDC) was used to collect data from the case report form. The clinical data manager designs the case report form (CRF) according to the clinical trial protocol, including the study process, data form name, and the data items it collects; The database programmer builds the electronic case report form (eCRF) based on the CRF and builds the EDC database. An eCRF completion guide is written by a clinical data manager. The Clinical Data Manager (CDM) develops a Data Management Plan (DMP) based on the clinical trial protocol. The data management plan serves as a guiding document for the entire data management process, and all data management processes should be operated in accordance with the time, content and method defined therein.

数据管理委员会:

Data Managemen Committee:

暂未确定

Not yet

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above